News
July 14, 2010 - Result of AGM
Cyprotex PLC ("Cyprotex" or the "Company")
Results of Annual General Meeting
At the Annual General Meeting of Cyprotex (AIM:CRX), the drug discovery technology and information company, held today all resolutions were passed.
Copies of the approved resolutions will be submitted to the UK Listing Authority and will shortly be available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at:
Financial Services Authority
25 The North Colonnade
Canary Wharf
London E14 5HS
Tel: +44 (0) 20 7676 1000
For further information:
Cyprotex PLC
Dr Anthony Baxter, Chief Executive Officer
John Dootson, Chief Financial Officer
Tel: +44 (0) 1625 505 100
ir@cyprotex.com
www.cyprotex.com
Singer Capital Markets Ltd
Shaun Dobson
Claes Spång
Tel: +44 203 205 7500
www.singercm.com
Financial Dynamics
Tel: +44 (0) 20 7831 3113
Ben Brewerton / Ben Atwell / Mo Noonan
cyprotex@fd.com
www.fd.com
